Becton Dickinson Profit Margin 2010-2023 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of December 31, 2023 is 6.44%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.091B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.816B 18.42
Cardinal Health (CAH) United States $27.159B 16.33
West Pharmaceutical Services (WST) United States $26.191B 44.22
Align Technology (ALGN) United States $23.160B 45.89
Cooper (COO) United States $18.783B 29.53
Labcorp (LH) United States $18.065B 15.43
Henry Schein (HSIC) United States $9.939B 17.00
DENTSPLY SIRONA (XRAY) United States $7.055B 18.00
Merit Medical Systems (MMSI) United States $4.628B 26.62
Patterson (PDCO) United States $2.478B 11.48
CONMED (CNMD) United States $2.448B 23.07
STAAR Surgical (STAA) United States $1.542B 48.55
Atrion (ATRI) United States $0.639B 30.05
Lifevantage (LFVN) United States $0.090B 14.60
Pro-Dex (PDEX) United States $0.059B 22.59
Biolase (BIOL) United States $0.003B 0.00